FREE Account Opening + No Clearing Fees

Paradeep Phosphates IPO review (Apply)

Review By Dilip Davda on May 12, 2022

•    PPL is the second-largest non-urea fertilizers manufacturer.
•    The company has posted growth in its bottom lines for the reported periods.
•    The issue is reasonably priced on the given parameters.
•    Investors may consider investment for the medium to long term.

Paradeep Phosphates Ltd. (PPL) is the second-largest private-sector manufacturer of non-urea fertilizers in India in terms of Di-Ammonium Phosphate ("DAP") volume sales for the nine months ended December 31, 2021 (Source: CRISIL Report). 

PPL is primarily engaged in manufacturing, trading, distribution and sales of a variety of complex fertilizers such as DAP, three grades of Nitrogen-Phosphorus-Potassium ("NPK") (namely NPK-10, NPK-12 and NP-20), Zypmite, Phospho-gypsum and Hydroflorosilicic Acid ("HFSA"). It is also engaged in the trading, distribution and sales of Muriate of Potash ("MOP"), Ammonia, Speciality Plant Nutrients ("SPN") and City compost. PPL's fertilizers are marketed under some of the key brand names in the market 'Jai Kisaan - Navratna' and 'Navratna'. It has an established track record of delivering robust financial performance.

The Company was incorporated in 1981. Zuari Maroc Phosphates Private Limited ("ZMPPL"), a joint venture of Zuari Agro Chemicals Limited ("ZACL") and OCP Group S.A. ("OCP"), currently holds 80.45% of the equity share capital of the Company, with the balance being held by the Government of India.

PPL is a part of the Adventz Group, as well as OCP. The Adventz Group operates in several businesses and has a strong presence in the agribusiness, engineering and infrastructure businesses and emerging lifestyle businesses. OCP, founded in 1920, with revenues of over US$6.3 billion in 2020, is one of the leading producers of Phosphate rock globally and operates largely in the Morocco and Western Sahara region which has approximately70% of the global Phosphate rock reserves, according to CRISIL Research, and is owned 95% by the Moroccan government. 

Phosphate rock is processed to produce phosphorous, which is one of the three main nutrients most commonly used in fertilizers (the other two are nitrogen and potassium). India has negligible Phosphate reserves and is dependent on imports of Phosphate rock (a source raw material) or Phosphoric Acid (an intermediate raw material) or DAP (finished phosphatic fertilizer). As of March 31, 2022, PPL employed 905 permanent personnel. It has also hired six consultants and hires contract labour for operations from time to time.

PPL distributes products across 14 states in India through various private and institutional channels, as of March 31, 2022. As of the same date, it has set up a network of 11 regional marketing offices and 468 stock points in 14 states across India. Its network comprised 4,761 dealers and over 67,150 retailers, catering to five million estimated farmers in India. Further, it has a dedicated team of 70 marketing officers, 9 junior agronomists and 71 field assistants, as of March 31, 2022.

To part finance its funding needs for part financing acquisition of Goa facility (Rs. 520.00 cr.), repayment/prepayment of certain borrowings (Rs. 300 cr.), and general corporate purposes, PPL is coming out with a maiden combo offer of fresh equity and Offer for sale (OFS) to garner Rs. 1501.73 cr. at the upper cap. The company has fixed a price band of Rs. 39 - Rs. 42 per share of Rs. 10 each. Minimum application is to be made for 350 shares and in multiples thereon, thereafter. The issue opens for subscription on May 17, 2022, and will close on May 19, 2022. Post allotment, shares will be listed on BSE and NSE. PPL will issue approx. 239047550 fresh equity shares worth Rs. 1004.00 cr. at the upper cap. With the OFS of 118507493 shares (approx. Rs. 497.73 cr.) the total issue will be for 357555043 equity shares. The issue constitutes 43.90% of the post issue paid-up capital of the company.

The issue is jointly lead managed by Axis Capital Ltd., ICICI Securities Ltd., J M Financial Ltd. and SBI Capital Markets Ltd. while Link Intime India Pvt. Ltd. is the registrar to the issue. 

Having issued most of the equity at par value, it converted loan and preference shares at a consideration other than cash (on the basis of Rs. 10 FV). The average cost of acquisition of shares by the promoters/selling stakeholders is Rs. 7.3691 and Rs. 10.00 per share. 

Post-IPO, PPL's current paid-up equity capital of Rs. 575.45 cr. will stand enhanced to Rs. 814.50 cr. At the upper cap of the IPO price, the company is looking for a market cap of Rs. 3420.89 cr.

On the financial performance front, for the last three fiscals, PPL has (on a consolidated basis) posted turnover/net profits of Rs. 4397.21 cr. / Rs. 158.96 cr. (FY19), Rs. 4227.78 cr. / Rs. 193.22 cr. (FY20) and Rs. 5183.94 cr. / Rs. 223.27 cr. (FY21). For the first nine months of FY22 ended on December 31, 2021, it has earned a net profit of Rs. 362.78 cr. on a turnover of Rs. 5973.69 cr. While it marked growth in top lines for the reported periods except for FY20, it continued to mark improvements in its bottom lines.

For the last three fiscals, PPL has posted an average EPS of Rs. 3.52 and an average RoNW of 11.91%. The issue is priced at a P/BV of 1.10 based on its NAV of Rs. 38.04 per share as of December 31, 2021, and at a P/BV of 1.07 based on its post-IPO NAV of Rs. 39.20 per share. 

If we annualise 9M-FY22 results and attribute it to post IPO fully diluted equity capital, then the asking price is at a P/E of around 7.07. 

As per offer documents, PPL has shown Coromandel Intl., Chambal Fertilizers and Deepak Fertilizers as its listed peers. They are currently trading at a P/E of 18.13, 13.70 and 36.31 (as of May 12, 2022). However, they are not truly comparable on an apple-to-apple basis. 

PPL has paid a dividend of 10% for FY19 and FY20 and thereafter it has not announced any dividend. It will adopt a prudent dividend policy post listing based on its financial performance and future prospects. 

The four merchant bankers associated with this issue have track records as under:

Axis Capital Ltd.: This is the 37th mandate from Axis Cap in the last three fiscals (including the ongoing one). Out of the last 10 listings, 3 opened at a discount and the rest with premiums ranging from 1.16% to 169.04% on the day of listings. 

ICICI Securities Ltd.: This is the 41st mandate from ICICI Sec in the last three fiscals (including the ongoing one). Out of the last 10 listings, 4 opened at a discount and the rest with premiums ranging from 0.06% to 169.04% on the day of listings.

J M Financial Ltd.: This is the 26th mandate from J M Fin in the last three fiscals (including the ongoing one). Out of the last 10 listings, all opened with premiums ranging from 0.04% to 89.86% on the day of listings.

SBI Capital Markets Ltd.: This is the 18th mandate from SBI Cap in the last three fiscals (including the ongoing one). Out of the last 10 listings, 5 opened at a discount and the rest with premiums ranging from 0.06% to 103.11% on the day of listings.

Conclusion / Investment Strategy

PPL is the second-largest non-urea fertiliser manufacturer in the country. Considering the primary thrust on the agriculture segment by the Government, this company is poised for bright prospects in the future. The issue is too reasonably priced and is worth considering for medium to long term rewards.

Reviewer recommends Subscribing to the issue.

Review By Dilip Davda on May 12, 2022

Review Author

DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor before making any actual investment decisions, based on the information published here. My reviews do not cover GMP market and operators game plans. Any reader taking decisions based on any information published here does so entirely at their own risk. Investors should bear in mind that any investment in stock markets is subject to unpredictable market-related risks. The above information is based on RHP and other documents available as of date coupled with market perception. The author has no plans to invest in this offer.

About Dilip Davda

Dilip Davda, a freelance journalist

Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.

Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detail fundamental and financial analysis of companies coming up with IPO helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.

(Dilip Davda -SEBI registered Research Analyst-Mumbai,

Registration no. INH000003127 (Perpetual)

Email id: ).

Paradeep Phosphates IPO FAQs

  1. 1. Why Paradeep Phosphates IPO?

    The initial public offer (IPO) of Paradeep Phosphates Limited offers an early investment opportunity in Paradeep Phosphates Limited. A stock market investor can buy Paradeep Phosphates IPO shares by applying in IPO before Paradeep Phosphates Limited shares get listed at the stock exchanges. An investor could invest in Paradeep Phosphates IPO for short term listing gain or a long term.

  2. 2. How is Paradeep Phosphates IPO?

    Read the Paradeep Phosphates IPO recommendations by the leading analyst and leading stock brokers.

  3. 3. Paradeep Phosphates IPO what should investors do?

    Paradeep Phosphates IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges. Read the Paradeep Phosphates IPO Notes, Analysis and Recommendations by leading stock brokerage firms and experts in the above answer.

  4. 4. Is Paradeep Phosphates IPO good?

    Our recommendation for Paradeep Phosphates IPO is to subscribe.

  5. 5. Is Paradeep Phosphates IPO worth Investing?

    As per the analysis by our lead analyst Mr. Dilip Davda, we suggest you to subscribe to the Paradeep Phosphates IPO.

  6. 6. When will Paradeep Phosphates IPO allotment status?

    The Paradeep Phosphates IPO allotment status will be available on or around May 24, 2022. The allotted shares will be credited in demat account by May 26, 2022. Visit Paradeep Phosphates IPO allotment status to check.

  7. 7. When will Paradeep Phosphates IPO list?

    The Paradeep Phosphates IPO will list on Friday, May 27, 2022, at BSE, NSE.


1. k l patel     Link|May 16, 2022 3:37:56 PM
sir for most of the companies latest 6 or 9 month results looks fishy, so pls calculate asking price P/E and EPS based on last year results..
thanks for unbiased reviews
1.1. Murtaza Mahuvawala     Link|May 19, 2022 1:30:10 PM
Seeing the amount of subsidies given by the government to ferlizer companies, I think seeing the P/E ratio and EPS is not enough to analyse this stock. There are many prospects for this company to grow.